Safety and Efficacy of Diacerein 1% Ointment Topical Formulation Compared to Placebo for Subjects With Epidermolysis Bullosa Simplex (EBS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03154333
Recruitment Status : Terminated (An independent data monitoring committee suggested that the study will not meet statistical objectives.)
First Posted : May 16, 2017
Last Update Posted : October 22, 2018
Information provided by (Responsible Party):
Castle Creek Pharmaceuticals, LLC

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : October 15, 2018
  Actual Study Completion Date : October 15, 2018